Clinical Trials Browser

OTHER × Melanoma × Rituximab × Clear all

NCT03719131 2025-04-22

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Phase 2 Active not recruiting

15 enrolled 10 charts

Melanoma

NCT02142335 2014-05-20

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Phase 2 Unknown

Melanoma

NCT01032122 2013-04-25

Rituximab in Metastatic Melanoma

Phase 1 Terminated

Melanoma, Neoplasm Metastasis